La leucemia mieloide aguda: anticuerpos dirigidos IL1RAP humana (IL1R3) muestran efectos terapéuticos en modelos de xenoinjerto

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553807/

https://translate.google.com/translate?sl=en&tl=es&js=y&prev=_t&hl=es&ie=UTF-8&u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4553807%2F&edit-text=&act=url